Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation.
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM. Garofalo M, et al. Among authors: pichiorri f. Cancer Cell. 2022 Nov 14;40(11):1440. doi: 10.1016/j.ccell.2022.10.005. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306794 Free PMC article. No abstract available.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Cancer Cell. 2022 Nov 14;40(11):1442. doi: 10.1016/j.ccell.2022.10.007. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306791 Free article. No abstract available.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Cancer Cell. 2022 Nov 14;40(11):1441. doi: 10.1016/j.ccell.2022.10.006. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306793 Free PMC article. No abstract available.
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy.
Adhikarla V, Awuah D, Caserta E, Minnix M, Kuznetsov M, Krishnan A, Wong JYC, Shively JE, Wang X, Pichiorri F, Rockne RC. Adhikarla V, et al. Among authors: pichiorri f. Front Immunol. 2024 Apr 18;15:1358478. doi: 10.3389/fimmu.2024.1358478. eCollection 2024. Front Immunol. 2024. PMID: 38698840 Free PMC article.
Genomic Frequencies of Dynamic DNA Sequences and Mammalian Lifespan.
Martella M, Carlesso N, Waller ZAE, Marcucci G, Pichiorri F, Smith SS. Martella M, et al. Among authors: pichiorri f. Cancer Genomics Proteomics. 2024 May-Jun;21(3):238-251. doi: 10.21873/cgp.20443. Cancer Genomics Proteomics. 2024. PMID: 38670588 Free PMC article.
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expression.
Murtadha M, Park M, Zhu Y, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer M, Dona AA, Vahed H, Gonzalez A, Ly K, Ouyang C, Sanchez JF, Nigam L, Duplan A, Chowdhury A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams JC, Pichiorri F. Murtadha M, et al. Among authors: pichiorri f. Blood. 2024 Apr 18;143(16):1599-1615. doi: 10.1182/blood.2023021570. Blood. 2024. PMID: 38394668
DiSCIoser: unlocking recovery potential of arm sensorimotor functions after spinal cord injury by promoting activity-dependent brain plasticity by means of brain-computer interface technology: a randomized controlled trial to test efficacy.
Colamarino E, Lorusso M, Pichiorri F, Toppi J, Tamburella F, Serratore G, Riccio A, Tomaiuolo F, Bigioni A, Giove F, Scivoletto G, Cincotti F, Mattia D. Colamarino E, et al. Among authors: pichiorri f. BMC Neurol. 2023 Nov 21;23(1):414. doi: 10.1186/s12883-023-03442-w. BMC Neurol. 2023. PMID: 37990160 Free PMC article. Clinical Trial.
The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trial.
Cipriani M, Pichiorri F, Colamarino E, Toppi J, Tamburella F, Lorusso M, Bigioni A, Morone G, Tomaiuolo F, Santoro F, Cordella D, Molinari M, Cincotti F, Mattia D, Puopolo M. Cipriani M, et al. Among authors: pichiorri f. Trials. 2023 Nov 16;24(1):736. doi: 10.1186/s13063-023-07773-4. Trials. 2023. PMID: 37974284 Free PMC article. Clinical Trial.
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.
Canella A, Nieves HC, Sborov DW, Cascione L, Radomska HS, Smith E, Stiff A, Consiglio J, Caserta E, Rizzotto L, Zanesi N, Stefano V, Kaur B, Mo X, Byrd JC, Efebera YA, Hofmeister CC, Pichiorri F. Canella A, et al. Among authors: pichiorri f. Oncotarget. 2023 Sep 25;14:837-838. doi: 10.18632/oncotarget.28515. Oncotarget. 2023. PMID: 37747363 Free PMC article. No abstract available.
Editorial: Women in brain-computer interfaces.
Lugo ZR, Cinel C, Jeunet C, Pichiorri F, Riccio A, Wriessnegger SC. Lugo ZR, et al. Among authors: pichiorri f. Front Hum Neurosci. 2023 Aug 22;17:1260479. doi: 10.3389/fnhum.2023.1260479. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37674934 Free PMC article. No abstract available.
140 results